Novara Therapeutics

Private

LondonHealthcare & Life Sciences

Last Round

Joint Venture

Aug 26, 2020

Company Overview

Novara Therapeutics is a life sciences company that develops bone-targeting contrast agents for the diagnosis and treatment of bone fractures and osteoporosis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Imaging, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

contrast agentbone imagingtheranosticsMRI contrastosteoporosis diagnosisX-ray contrastmedical imagingbiotechnologybone microfracturesdrug discoverypre-clinical researchradiologymolecular imagingbio-specific imagingorthopaedic research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Novara Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Novara Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Novara Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Joint Venture	Aug 26, 2020

View all Funding Rounds

Novara Therapeutics Investors

Notable investors and investment history

Novara Therapeutics investors
Investor	Rounds
Embryo Ventures	Joint Venture
Orthopaedic Research UK	Joint Venture

View all Investors

Novara Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Novara Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Novara Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon

Year Founded2020

Last FundingAug 26, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.